Thematics Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Thematics Asset Management's VRTX Position: Q3 2025 in Review
Thematics Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q3 2025, buying an estimated $849K and bringing the position to 12,629 shares worth $4.95M. The position accounts for 0.22% of the portfolio, ranked #100.
Thematics Asset Management first reported a position in VRTX in Q4 2024 and has held it in 4 quarters since. 1,520 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.
- Thematics Asset Management held 12,629 shares of Vertex Pharmaceuticals worth $4.95M as of Q3 2025.
- Thematics Asset Management bought 2,031 Vertex Pharmaceuticals shares in Q3 2025, an estimated $849K.
- Vertex Pharmaceuticals made up 0.22% of Thematics Asset Management's portfolio in Q3 2025, its #100 holding.
- Thematics Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
- 1,520 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.
Based on Thematics Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.